John D Markman

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. doi request reprint Not so fast: the reformulation of fentanyl and breakthrough chronic non-cancer pain
    John D Markman
    Pain 136:227-9. 2008
  2. pmc Evaluation of outcome measures for neurogenic claudication: A patient-centered approach
    John D Markman
    From the Department of Neurosurgery, Translational Pain Research Program J D M, M E F, C P, B S J, and Departments of Anesthesiology J S G, R H D and Biostatistics and Computational Biology X C, University of Rochester School of Medicine and Dentistry, NY Department of Anesthesiology and Pain Medicine K V P, University of Washington, Seattle LORA Group, LLC L B B, Royal Oak, MD and Department of Biostatistics and Epidemiology J T F, University of Pennsylvania, Philadelphia
    Neurology 85:1250-6. 2015
  3. pmc Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication
    John D Markman
    From the Department of Neurosurgery, Translational Pain Research Program J D M, M E F, S A R, K C, W H P, and Departments of Biostatistics and Computational Biology M P M, A K C, Neurology M P M, A K C, and Anesthesiology J S G, R H D, University of Rochester School of Medicine and Dentistry, Rochester, NY and SDG LLC L S S, Cambridge, MA
    Neurology 84:265-72. 2015
  4. ncbi request reprint Ion channel targets and treatment efficacy in neuropathic pain
    John D Markman
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Pain 7:S38-47. 2006
  5. doi request reprint Lumbar spinal stenosis in older adults: current understanding and future directions
    John D Markman
    Neuromedicine Pain Management Center, University of Rochester School of Medicine and Dentistry, Department of Neurosurgery, 601 Elmwood Avenue, Box 670, Rochester, NY 14642, USA
    Clin Geriatr Med 24:369-88, viii. 2008
  6. ncbi request reprint Interventional approaches to pain management
    John D Markman
    Neuromedicine Pain Management Center, Department of Neurosurgery and Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 670 Rochester, New York 14642, USA
    Anesthesiol Clin 25:883-98, viii. 2007
  7. ncbi request reprint Interventional approaches to pain management
    John D Markman
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Med Clin North Am 91:271-86. 2007
  8. doi request reprint A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis
    John D Markman
    Department of Neurosurgery, Translational Pain Research Program, University of Rochester, Rochester, NY Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY Surgery Cancer Control Unit, University of Rochester, Rochester, NY and Departments of Biostatistics and Computational Biology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY
    Spine (Phila Pa 1976) 40:684-91. 2015
  9. doi request reprint Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
    Jennifer S Gewandter
    aDepartment of Anesthesiology, University of Rochester, Rochester, NY, USA bUniversity of Washington, Seattle, WA, USA cUniversity of Pennsylvania, Philadelphia, PA, USA dUniversity of Florida, Gainesville, FL, USA eQueen s University, Kingston, ON, Canada fHarvard University, Boston, MS, USA gJohns Hopkins University, Baltimore, MD, USA hGerman Diabetes Center at Heinrich Heine University, Dusseldorf, Germany iLora Group, LLC, Royal Oak, MD, USA jAmerican Chronic Pain Association, Rocklin, CA, USA kPfizer and Duke University, Raleigh Duram, NC, USA lGlaxoSmithKline, London, United Kingdom mEli Lilly, Indianapolis, IN, USA nVirtuous Pharma, Inc, Raleigh Durham, NC, USA oYork University, Toronto, UK
    Pain 156:1184-97. 2015
  10. doi request reprint Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations
    Ann M Taylor
    aCentre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom bDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA cDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA dDepartment of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA eDepartment of Occupational Science and Occupational Therapy, University of Toronto, ON, Canada fInstitute for Work and Health, University of Toronto, ON, Canada gDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA hInstitute for Work and Health, University of Toronto, ON, Canada iDepartment of Neurology, University of Rochester, Rochester, NY, USA jDepomed, Newark, CA, USA kLORAGroup LLC, Royal Oak, MD, USA lDepartment of Health Services Research University of Maryland, Baltimore, MD, USA mPublic Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA nDivision of Infection and Immunity, Cardiff University, Cardiff, Sweden
    Pain 157:1836-50. 2016

Collaborators

Detail Information

Publications16

  1. doi request reprint Not so fast: the reformulation of fentanyl and breakthrough chronic non-cancer pain
    John D Markman
    Pain 136:227-9. 2008
  2. pmc Evaluation of outcome measures for neurogenic claudication: A patient-centered approach
    John D Markman
    From the Department of Neurosurgery, Translational Pain Research Program J D M, M E F, C P, B S J, and Departments of Anesthesiology J S G, R H D and Biostatistics and Computational Biology X C, University of Rochester School of Medicine and Dentistry, NY Department of Anesthesiology and Pain Medicine K V P, University of Washington, Seattle LORA Group, LLC L B B, Royal Oak, MD and Department of Biostatistics and Epidemiology J T F, University of Pennsylvania, Philadelphia
    Neurology 85:1250-6. 2015
    ....
  3. pmc Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication
    John D Markman
    From the Department of Neurosurgery, Translational Pain Research Program J D M, M E F, S A R, K C, W H P, and Departments of Biostatistics and Computational Biology M P M, A K C, Neurology M P M, A K C, and Anesthesiology J S G, R H D, University of Rochester School of Medicine and Dentistry, Rochester, NY and SDG LLC L S S, Cambridge, MA
    Neurology 84:265-72. 2015
    ..To test the effects of pregabalin on the induction of neurogenic claudication...
  4. ncbi request reprint Ion channel targets and treatment efficacy in neuropathic pain
    John D Markman
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    J Pain 7:S38-47. 2006
    ....
  5. doi request reprint Lumbar spinal stenosis in older adults: current understanding and future directions
    John D Markman
    Neuromedicine Pain Management Center, University of Rochester School of Medicine and Dentistry, Department of Neurosurgery, 601 Elmwood Avenue, Box 670, Rochester, NY 14642, USA
    Clin Geriatr Med 24:369-88, viii. 2008
    ....
  6. ncbi request reprint Interventional approaches to pain management
    John D Markman
    Neuromedicine Pain Management Center, Department of Neurosurgery and Neurology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 670 Rochester, New York 14642, USA
    Anesthesiol Clin 25:883-98, viii. 2007
    ....
  7. ncbi request reprint Interventional approaches to pain management
    John D Markman
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Med Clin North Am 91:271-86. 2007
    ....
  8. doi request reprint A Randomized, Double-blind, Placebo-Controlled Crossover Trial of Oxymorphone Hydrochloride and Propoxyphene/Acetaminophen Combination for the Treatment of Neurogenic Claudication Associated With Lumbar Spinal Stenosis
    John D Markman
    Department of Neurosurgery, Translational Pain Research Program, University of Rochester, Rochester, NY Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY Surgery Cancer Control Unit, University of Rochester, Rochester, NY and Departments of Biostatistics and Computational Biology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY
    Spine (Phila Pa 1976) 40:684-91. 2015
    ..Randomized, double-blind, placebo-controlled, single-dose crossover study...
  9. doi request reprint Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations
    Jennifer S Gewandter
    aDepartment of Anesthesiology, University of Rochester, Rochester, NY, USA bUniversity of Washington, Seattle, WA, USA cUniversity of Pennsylvania, Philadelphia, PA, USA dUniversity of Florida, Gainesville, FL, USA eQueen s University, Kingston, ON, Canada fHarvard University, Boston, MS, USA gJohns Hopkins University, Baltimore, MD, USA hGerman Diabetes Center at Heinrich Heine University, Dusseldorf, Germany iLora Group, LLC, Royal Oak, MD, USA jAmerican Chronic Pain Association, Rocklin, CA, USA kPfizer and Duke University, Raleigh Duram, NC, USA lGlaxoSmithKline, London, United Kingdom mEli Lilly, Indianapolis, IN, USA nVirtuous Pharma, Inc, Raleigh Durham, NC, USA oYork University, Toronto, UK
    Pain 156:1184-97. 2015
    ..Additionally, standardization of outcomes in prevention clinical trials will facilitate meta-analyses and systematic reviews and improve detection of preventive strategies emerging from clinical trials. ..
  10. doi request reprint Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations
    Ann M Taylor
    aCentre for Medical Education, School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom bDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA cDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA dDepartment of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA eDepartment of Occupational Science and Occupational Therapy, University of Toronto, ON, Canada fInstitute for Work and Health, University of Toronto, ON, Canada gDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI, USA hInstitute for Work and Health, University of Toronto, ON, Canada iDepartment of Neurology, University of Rochester, Rochester, NY, USA jDepomed, Newark, CA, USA kLORAGroup LLC, Royal Oak, MD, USA lDepartment of Health Services Research University of Maryland, Baltimore, MD, USA mPublic Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA nDivision of Infection and Immunity, Cardiff University, Cardiff, Sweden
    Pain 157:1836-50. 2016
    ..We provide recommendations regarding important domains to stimulate research to develop tools that are more robust, address consistency and standardization, and engage patients early in tool development. ..
  11. doi request reprint Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
    Robert H Dworkin
    Departments of Anesthesiology and Neurology and Center for Human Experimental Therapeutics, University of Rochester, Rochester, NY 14642, USA
    Pain 153:1148-58. 2012
    ....
  12. doi request reprint Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study
    Shannon M Smith
    Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York Electronic address
    J Pain . 2016
    ..Understanding the preferences of potential participants is an important step toward enhancing enrollment in pain treatment trials...
  13. doi request reprint Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
    Robert R Edwards
    aHarvard Medical School, Boston, MA, USA bUniversity of Rochester, Rochester, NY, USA cUniversity of Washington, Seattle, WA, USA dStanford University, Palo Alto, CA, USA eEast Carolina University, Greenville, NC, USA fOslo University Hospital, Oslo, Norway and Karolinska Institute, Stockholm, Sweden gWashington University, St Louis, MO, USA hAalborg University, Aalborg, Denmark iHôpital Ambroise Paré, APHP and INSERM U 987, Boulogne Billancourt, France and University Versailles Saint Quentin, Versailles, France jUniversity of Kiel, Kiel, Germany kMetroHealth Medical Center, Cleveland, OH, USA lDepomed, Newark, CA, USA mLORA Group, LLC, Royal Oak, MD, USA nUniversity of Maryland, Baltimore, MD,
    Pain 157:1851-71. 2016
    ..We provide evidence-based recommendations for core phenotyping domains and recommend measures of each domain. ..
  14. doi request reprint Interpretation of urine drug testing results in patients using transdermal buprenorphine preparations for the treatment of chronic noncancer pain
    John D Markman
    Department of Neurosurgery, University of Rochester, New York, 14642, USA
    Pain Med 16:1132-6. 2015
    ....
  15. ncbi request reprint Pain associated with multiple sclerosis: systematic review and proposed classification
    Alec B O'Connor
    Department of Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Pain 137:96-111. 2008
    ..Suggestions for future studies that would increase understanding of the natural history, mechanisms, and treatment of pain in patients with MS are presented...
  16. ncbi request reprint Gabapentin in the operating room: clear for discharge?
    John D Markman
    Neurology 67:1116-7. 2006